Funding Tracker/OpenEvidence
Series E · Clinical AI / Evidence · United States
OpenEvidence raises $250M
Announced September 28, 2026
The round
OpenEvidence announced a Series E round of $250M on September 28, 2026, led by Andreessen Horowitz, Byers Capital.
The Signal$15B valuation confirmation for the clinician evidence AI platform after another large growth check.
What OpenEvidence does
Point of care answers grounded in the published literature, with citations.
OpenEvidence is a free, ad-supported clinical reference used at the point of care. It answers physician questions using licensed journal and guideline content, with citations attached to each reply. Verified clinicians use it at no cost, while medical publishers and advertisers fund the platform.
Full OpenEvidence profile- Company
- OpenEvidence
- Amount
- $250M
- Stage
- Series E
- Announced
- September 28, 2026
- Led by
- Andreessen Horowitz, Byers Capital
- Vertical
- Clinical AI / Evidence
- Country
- United States
- Headquarters
- Miami, United States
- Founded
- 2022